The Nigerian government, in partnership with a multinational healthcare company, Roche and digital healthcare provider, Oncopadi Technologies, has launched the Breast Cancer Access Navigation and Testing (BRANT) Programme—an initiative aimed at supporting breast cancer patients across Nigeria.
The programme aims to enhance early detection and ensure timely, accurate breast cancer diagnosis by offering free immunohistochemistry tests, multidisciplinary care, and navigation services to 5,000 Nigerian women.”
Speaking at the launch of the programme in Abuja on Thursday, the Director- General, National Institute for Cancer Research and Treatment, Usman Aliyu, noted that BRANT is a milestone in the nation’s continuous effort to enhance patient care, streamline support systems, and empower individuals battling the disease.
